Eli Lilly & Co.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2018
Total Assets: $43.91B
Liabilities Breakdown FY2018
Total Liabilities: $34.08B
Asset Breakdown
Total Assets: $43.91B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.32B | 16.7% |
| Accounts Receivable | $4.59B | 10.5% |
| Inventory | $3.10B | 7.1% |
| Property, Plant & Equipment | $8.00B | 18.2% |
| Goodwill | $1.37B | 3.1% |
| Intangible Assets | $1.07B | 2.4% |
| Other Assets | $18.47B | 42.1% |
Liabilities Breakdown
Total Liabilities: $34.08B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.21B | 3.5% |
| Long-Term Debt | $9.20B | 27.0% |
| Other Liabilities | $23.68B | 69.5% |